fentanyl

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 437-38-7

Where It Comes From

10 FDA-registered drug labelers
ALVOGEN
Aveva Drug Delivery Systems Inc.
Cambrex Charles City, Inc
Catalent Micron Technologies, Inc.
Chattem Chemicals, Inc.
INGENUS PHARMACEUTICALS, LLC
Mylan Pharmaceuticals Inc.
Siegfried Grafton, Inc.
SpecGx LLC
Veranova, L.P.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • Fentanyl
  • Fentanyl Transdermal
  • Fentanyl system
FDA Shortage Status
Active Shortage
Shortage History
current

Fentanyl Citrate Injection

12/20/2023

Unavailable

current

Fentanyl Citrate Injection

01/01/2012

Unavailable

current

Fentanyl Citrate Injection

12/20/2023

Available

current

Fentanyl Citrate Injection

01/01/2012

Available

current

Fentanyl Citrate Injection

01/01/2012

Limited Availability

Chemical Identity

CAS437-38-7
PubChem CID3345
DTXSIDDTXSID9023049
FormulaC22H28N2O
Mol. Weight336.5 g/mol
SMILESCCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3

Data Sources

33452026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/fentanyl/cids/JSON

Archive: data/sources/pubchem_name/fentanyl.json

CAS 437-38-72026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 437-38-72026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json